EA199900352A1 - Композиции жидкого алендроната - Google Patents

Композиции жидкого алендроната

Info

Publication number
EA199900352A1
EA199900352A1 EA199900352A EA199900352A EA199900352A1 EA 199900352 A1 EA199900352 A1 EA 199900352A1 EA 199900352 A EA199900352 A EA 199900352A EA 199900352 A EA199900352 A EA 199900352A EA 199900352 A1 EA199900352 A1 EA 199900352A1
Authority
EA
Eurasian Patent Office
Prior art keywords
liquid
alandronate
compositions
composition
hcl
Prior art date
Application number
EA199900352A
Other languages
English (en)
Other versions
EA001213B1 (ru
Inventor
Маниш Дж. Неруркар
Вильям А. Ханке
Дразен Остовиц
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA199900352A1 publication Critical patent/EA199900352A1/ru
Publication of EA001213B1 publication Critical patent/EA001213B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Жидкая композиция алендроновой кислоты или фармацевтически приемлемой соли имеет достаточные буферные свойства, так что рН композиции равняется 4-7,5, и 15 мл композиции может увеличить рН 50 мл 0,1 н HCl от 1 до, по крайней мере, 3, предпочтительно до 4.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900352A 1996-10-04 1997-10-02 Композиции жидкого алендроната EA001213B1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2676596P 1996-10-04 1996-10-04
GBGB9700541.7A GB9700541D0 (en) 1997-01-13 1997-01-13 Liquid alendronate formulation
US3600297P 1997-01-22 1997-01-22
PCT/US1997/015740 WO1998014196A1 (en) 1996-10-04 1997-10-02 Liquid alendronate formulations

Publications (2)

Publication Number Publication Date
EA199900352A1 true EA199900352A1 (ru) 1999-08-26
EA001213B1 EA001213B1 (ru) 2000-12-25

Family

ID=27268667

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900352A EA001213B1 (ru) 1996-10-04 1997-10-02 Композиции жидкого алендроната

Country Status (20)

Country Link
EP (1) EP1007054A4 (ru)
JP (1) JP2001501222A (ru)
CN (1) CN1238691A (ru)
AU (1) AU723357B2 (ru)
BG (1) BG103306A (ru)
BR (1) BR9712197A (ru)
CA (1) CA2267370A1 (ru)
CZ (1) CZ116999A3 (ru)
EA (1) EA001213B1 (ru)
EE (1) EE03669B1 (ru)
HU (1) HUP0000125A3 (ru)
IL (1) IL129127A0 (ru)
IS (1) IS5012A (ru)
NO (1) NO991569L (ru)
NZ (1) NZ334836A (ru)
PL (1) PL332496A1 (ru)
SK (1) SK42999A3 (ru)
TR (1) TR199900730T2 (ru)
WO (1) WO1998014196A1 (ru)
YU (1) YU17499A (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297740T1 (de) 2001-01-23 2005-07-15 Gador Sa Bisphosphonate-enthaltenden zusammensetzungen zur vorbeugung und/oder heilung von metabolischen knochenkrankheiten, verfahren zu ihren herstellung und benutzung dieser zusammensetzungen
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
NZ567200A (en) * 2005-09-16 2010-08-27 Selamine Ltd Bisphosphonate formulation
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
JP2010043119A (ja) * 2009-10-16 2010-02-25 Gador Sa 骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) * 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Also Published As

Publication number Publication date
YU17499A (en) 1999-11-22
CZ116999A3 (cs) 1999-09-15
AU4644897A (en) 1998-04-24
EP1007054A1 (en) 2000-06-14
WO1998014196A1 (en) 1998-04-09
IS5012A (is) 1999-03-26
EP1007054A4 (en) 2000-07-19
PL332496A1 (en) 1999-09-13
EE9900113A (et) 1999-10-15
CN1238691A (zh) 1999-12-15
EA001213B1 (ru) 2000-12-25
HUP0000125A3 (en) 2001-04-28
NO991569L (no) 1999-06-04
SK42999A3 (en) 2000-01-18
EE03669B1 (et) 2002-04-15
BG103306A (en) 2000-01-31
NO991569D0 (no) 1999-03-30
JP2001501222A (ja) 2001-01-30
CA2267370A1 (en) 1998-04-09
AU723357B2 (en) 2000-08-24
NZ334836A (en) 2000-11-24
BR9712197A (pt) 1999-08-31
IL129127A0 (en) 2000-02-17
TR199900730T2 (xx) 1999-07-21
HUP0000125A2 (hu) 2000-06-28

Similar Documents

Publication Publication Date Title
EA199901100A1 (ru) Фармацевтические композиции, содержащие гемисульфат элетриптана и кофеин
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
EA199900979A1 (ru) Композиции активированного протеина
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
TR200200706T2 (tr) Nöropatik ağrı tedavisi için retigabin kullanımı.
EA199700285A1 (ru) Препарат, содержащий мономерный аналог инсулина, кристаллический аналог инсулина, способ его получения
HU9602229D0 (en) Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
ES2125477T3 (es) Composicion detergente lavavajillas concentrada, liquida o gelificada, que contiene xileno-sulfonato de calcio.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
PT814782E (pt) Composicao farmaceutica estabilizada com um agente basico
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
EA199900352A1 (ru) Композиции жидкого алендроната
EA200200479A1 (ru) Новые олигосахариды, их получение и содержащие их фармацевтические композиции
EA200100194A1 (ru) КРИСТАЛЛИЧЕСКИЕ ФОРМЫ ETO2C-CH2-(R)Cgl-Aze-Pab-OH
EA200100354A1 (ru) Фармацевтическая композиция, содержащая энтакапон или нитекапон, а также поперечно-сшитое производное целлюлозы
EA200100184A1 (ru) Новые гидратные формы алендроната натрия, способы их получения и фармацевтические композиции
EA199901013A1 (ru) Гели пролонгированного действия
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
EA199700160A1 (ru) Производные индола в качестве антагонистов eaa
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
EA200000198A1 (ru) 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU